Targeted microbiological testing to confirm the absence of objectionable microorganisms in medical device and pharmaceutical products, supporting regulatory compliance and patient safety.
Targeted microbiological testing to confirm the absence of objectionable microorganisms in medical device and pharmaceutical products, supporting regulatory compliance and patient safety.
Absence of specific organisms testing is used to confirm that defined objectionable microorganisms are not present in a product, component, or manufacturing process. In the medical device and pharmaceutical industries, microbiological quality is closely controlled to ensure that products are safe for patient use and meet strict regulatory requirements. Testing for the absence of specific organisms provides additional assurance that microbial contamination risks are effectively managed.
Unlike general microbial enumeration tests, which measure the total number of microorganisms present, absence testing focuses on detecting microorganisms that could negatively impact product safety or performance. This targeted approach supports risk based microbiological control strategies within regulated manufacturing environments.
Medical device and pharmaceutical manufacturers must demonstrate control of microbiological contamination throughout the manufacturing lifecycle. Absence of specific organisms testing can be applied to raw materials, components, water systems, in process samples, and finished products to verify that defined microorganisms are not present.
Objectionable organisms may vary depending on the product type, manufacturing environment, and intended clinical use. For example, microorganisms capable of surviving in low nutrient environments or forming biofilms in water systems may be considered particularly relevant in healthcare manufacturing. Absence testing therefore forms part of a broader environmental monitoring and microbiological quality programme that supports compliance with pharmacopoeial and regulatory guidance.
CLS provides absence of specific organisms testing tailored to the requirements of medical device and pharmaceutical manufacturers. Testing is performed using validated microbiological methods designed to detect targeted microorganisms while maintaining sensitivity, accuracy, and regulatory compliance.
The CLS microbiology laboratory works with clients to define appropriate testing strategies based on product risk, manufacturing processes, and applicable regulatory standards. With extensive experience supporting regulated healthcare industries, CLS delivers reliable testing services that help manufacturers demonstrate microbiological control, protect patient safety, and meet quality and compliance requirements.
Trusted by leading names